Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arthrotana is a dietary supplement developed by Harras Pharma Curarina designed to support joint health and cartilage function. It is formulated as oral granules containing a combination of collagen hydrolysate (skeletal proteins), glycosaminoglycans (cartilage basic substances), and vitamin C. Vitamin C is included to contribute to normal collagen formation, which is essential for the maintenance of normal cartilage function. The product is marketed as a consumer health supplement rather than a pharmaceutical drug and is typically administered by stirring the granules into food or beverages such as yogurt or milk.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Arthrotana.